AI Accelerator Grant (Global Ovarian Cancer Research Consortium)

About this program

The Ovarian Cancer Research Alliance (OCRA) provides a portfolio of grants to support innovative ovarian and related gynecologic cancer research—from pilot and mentored awards to large collaborative and AI‑driven initiatives—aimed at accelerating discoveries and improving survival. Key programs include the Global AI Accelerator (up to $1M over 3 years plus AWS compute credits; requires lead investigators from the US, UK, Canada and Australia and substantial AI integration), Collaborative Research Development and Microsoft AI for Good grants ($900K over 3 years), Early Career Investigator ($450K over 3 years), Mentored Investigator ($100K), Health Equity ($200K), and Rivkin Pilot ($100K), with awards paid to the institution of the principal investigator. Eligibility and requirements vary by program: AI Accelerator demands multinational leadership and significant AI use; Collaborative awards require multi‑investigator intra‑ or inter‑institutional teams; Early Career is for assistant‑professor‑level investigators; Mentored grants are for postdoctoral/clinical fellows with an MD or PhD and a sponsoring mentor; Health Equity grants focus on projects addressing barriers faced by marginalized communities, and all applications undergo rigorous review.